Tiziana Life Sciences (TILS)

 

TILS Share PerformanceMore

52 week high230.00 24/04/17
52 week low91.35 27/04/16
52 week change 71.50 (47.35%)
4 week volume112,440 29/03/17

Technical Insight

Login or Register to access technical insights.

Latest NewsMore

Broker Forecast - Beaufort Securities issues a broker note on Tiziana Life Sciences Plc Ord 3p

Beaufort Securities today reaffirms its speculative buy investment rating on Tiziana Life Sciences Plc Ord 3p (LON:TILS) ...

TILS confirms Phase II clinical trial protocol for Milciclib

Tiziana Life Sciences has announced the approval in Israel of a phase II clinical trial protocol for testing milciclib, a novel ...

Announces Approval of a Phase II Clinical Trial

Announces Publication of Milciclib Clinical Trial

A statement giving an update on research (e.g. clinical trials)

Tiziana Life Sciences notes exercise of warrants

Tiziana Life Sciences has received a notification from warrant holders to exercise warrants over 1.8m shares at an exercise...

Exercise of Warrants & Issue of Equity

Notification of an issue of equity shares e.g. offer for subscription/offer for sale/rights issue

Arun Sanyal appointed to Scientific Advisory Board

Warrant Expiry - Reminder

Miscellaneous medium priority announcements

Fundamental DataMore

EPS-9.5
Dividend yield0 %

Equity Research (TILS)

equity development
Tiziana Life Sciences PLC
26/01/2015
TILS has just announced an exclusive license with Nerviano Medical Sciences (NMS) for its Phase 2 anti-cancer drug candidate, milciclib. It helps block the rampant cell division associated with...
equity development
Tiziana Life Sciences PLC
12/01/2015
Tiziana (TILS) and Novimmune S.A., a company focused on the discovery and development of antibody-based drugs to benefit patients with inflammatory, auto-immune disorders, and cancer, have announced...
equity development
Tiziana Life Sciences PLC
30/09/2014
Tiziana Life Sciences (TILS) has identified a potential 'master regulator' for metastatic breast cancer (mBC). 'Bcl-3 inhibition' would be a novel strategy for treatment,...

Latest discussion posts More

  • Fundraise

    Beaufort Securities's note out this morning on Research Tree: "Tiziana progressed well during the FY2015. It strengthened its portfolio by acquiring exclusive licence for both ...
    8-Jun-2016
    Simbr
  • no buying

    With sp @110 and bid @ 115 I tried buying 2500 online at Barclays. Quoted 187.4 Obviously buying is being discouraged for whatever reason
    28-Apr-2016
    osammyboy
  • More cheap shares for the boys. When can we get some?
    15-Jan-2016
    osammyboy

Users' HoldingsMore

Users who hold Tiziana Life Sciences also hold..
ID:ISIN:GB00B474YB1265%
LLOYDS GRP.27%
ROYAL BANK SCOT23%
TAYLOR WIMPEY13%
MIRADA13%

Codes & Symbols

ISINGB00BKWNZY55
SymbolsTILS, LSE:TILS, TILS.L, TILS:LN, LON:TILS, XLON:TILS